bioxodes.com
Get leads like Bioxodes — and thousands more
Build targeted lists by tech stack, traffic, and more
Bioxodes: The $82M Bet on Stroke
A 17-person biotech taking on hemorrhagic stroke with Ir-CPI and massive funding
In a biotech landscape dominated by incrementalism, Bioxodes is making a high-stakes play for one of medicine's most devastating conditions. With $82.2M in funding and just 17 employees, they're not just building a drug—they're attempting to rewrite the playbook for hemorrhagic stroke treatment.
"They're not playing for a quick flip—they're building the infrastructure for a decade-long clinical battle."
The Ir-CPI Gamble
Bioxodes isn't chasing common targets. Their Ir-CPI drug candidate goes after hemorrhagic stroke—a space with historically brutal failure rates and massive unmet need. The $82.2M war chest suggests serious institutional conviction, but the 17-person team size reveals a disciplined, asset-focused strategy rather than platform sprawl.
The Funding-to-Traction Mismatch
Here's the tension: $82.2M in funding but only 840 monthly visits and 23% organic traffic. This isn't a consumer-facing biotech building hype. Their traffic profile screams 'stealth mode'—likely focused on clinical infrastructure, KOL relationships, and payer strategy rather than public awareness. The 50% direct traffic is the only signal that brand equity exists among stakeholders who matter.
Their keyword strategy reveals everything. Terms like 'ESOC 2025' and 'director of launch excellence' show they're already planning for commercialization years ahead. Meanwhile, low-volume searches for their own brand name suggest they're not wasting cycles on SEO theater. This is a company talking to neurologists and investors, not patients.
- 840 monthly visits is a feature, not a bug—they're not optimizing for vanity metrics
- Tailwind CSS + Bootstrap suggests rapid iteration without design debt
- Vimeo integration hints at medical education content for HCPs
- Twitter/LinkedIn presence is minimal but exists—classic pre-launch posture
The Verdict: A Quiet Giant
Bioxodes is playing the long game with institutional-grade capital and surgical focus. The question isn't whether they're serious—it's whether Ir-CPI can deliver in a space where giants have fallen.
What tech stack does Bioxodes use?
How much traffic does Bioxodes get?
Traffic & Engagement
Traffic Sources
Where is Bioxodes's audience located?
What keywords does Bioxodes rank for?
5 keywordsHow is Bioxodes's SEO?
Open Graph Image
https://bioxodes.com/resize/31/c80-1200x630/news-thumbnail-1.jpg
Meta Tags
A breakthrough for hemorrhagic stroke patients. | Bioxodes
Bioxodes is developing a novel drug candidate, Ir-CPI, for hemorrhagic stroke patients.
Home
Bioxodes is a clinical stage biopharmaceutical company developing a first-in-class drug candidate, Ir-CPI, for the prevention of thrombosis and neuroinflammation in hemorrhagic stroke patients.
Schema Types
What is Bioxodes's revenue?
Who works at Bioxodes?
Loading leads...
What do customers think of Bioxodes?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Bioxodes
What is Bioxodes's Revenue?
What does Bioxodes do?
How fast is Bioxodes growing?
What technologies does Bioxodes use?
Who are Bioxodes's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Bioxodes?
Contact Information
Export bioxodes.com Data
Download the complete tech stack, analytics, leads, and company data for bioxodes.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About bioxodes.com
Bioxodes is developing a novel drug candidate, Ir-CPI, for hemorrhagic stroke patients.
Company Overview
bioxodes.com Social Media
Contact bioxodes.com
Email Addresses
Phone Numbers
Technology Stack
bioxodes.com uses 7 technologies across their website including Google Maps, Vimeo, Twitter Cards, and more.
Maps
Google Maps
Video
Vimeo
Web Standards
Twitter Cards
Build Tools
Vite
CSS Frameworks
Bootstrap, Tailwind CSS
JavaScript Libraries
Splide
Traffic & Audience
bioxodes.com receives approximately 840 monthly visitors. The website has a bounce rate of 36% with visitors viewing an average of 1.1 pages per visit. Users spend an average of 0:00 on the site.
The majority of bioxodes.com's traffic comes from .
Frequently Asked Questions
What is bioxodes.com?
What technologies does bioxodes.com use?
How do I contact bioxodes.com?
What are bioxodes.com's social media accounts?
Is bioxodes.com hiring?
How popular is bioxodes.com?
Related Searches
This page provides publicly available information about bioxodes.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit bioxodes.com directly at https://bioxodes.com.